Gujerot Syndrome

Gougereau syndrome, or middle cerebral artery stenosis, is a rare but severe neurological condition characterized by decreased blood supply to the brain. This disease is also called MV1 aneurysm, which refers to medium-sized vessels. Damage to the vascular system of the brain leads to disturbances in consciousness and other brain functions, and can cause stroke, coma, strokes, dementia or death.

History of diagnosis and treatment Gougereau syndrome was first described in 1901 by French surgeon Jacques Gougereau. It characterizes the block of intracranial blood flow before a person recovers from apnea. This critical condition requires immediate medical attention. There are four stages of Gougerot syndrome, each of which has its own criteria for diagnosis. With mild damage, blood flow to the brain is restored, but with severe damage, the patient’s condition deteriorates. In addition, there is an intermediate form that negatively affects one important brain function and is accompanied by focal symptoms. The development of the syndrome often occurs unnoticed. Gougerot's disease causes damage to brain tissue (non-purulent). Can cause acute paralysis with simultaneous impairment of several brain functions. Diabetes mellitus contributes to the transition to a more severe stage. In recent years, Gougerot syndrome has been recorded not only as an isolated lesion of the cerebral vessels, but also as one of the signs of many more serious diseases. The lack of quick and correct diagnosis complicates the process due to the wide range of manifestations of the syndrome (it is diagnosed by an emergency physician). These include rapid breathing or heartbeat, frequent fainting, the presence of consciousness, its change, and speech disorders.